Biologicals

New technologies and risk mitigation strategies to detect, prevent and remediate viral contaminations in raw materials, cell culture processes and facilities throughout the entire supply chain.

IBC's Process & Product Validation conference provides insights into the interpretation and implementation of FDA's Process Validation Guidance and QbD approaches, while examining the roles and impact of knowledge management and quality risk management on continuous verification.

IBC's Outsourcing Manufacturing of Biopharmaceuticals conference provides you insights into developing your risk-mitigation strategies and operational excellence that oversees supply chain security and raw material reliability, thereby delivering a successful agent-sponsor relationship and ensuring consistent high quality products from your CMO partners.

IBC's Technology Transfer for Biopharmaceuticals gives you an inside look at trouble-shooting transfer challenges while developing strategies to minimize risk, enhance productivity, and ensure efficient and smooth technology transfers.

The flexibility of these 9 conferences taking place during IBC's Biopharmaceutical Development & Production Week, allows you to pick and choose the sessions that are the best fit for you so you can get the most out of your time at the event.

The Recombinant Protein & Complex Biologic Development & Production conference covers the entire spectrum of topics related to improving the efficiency of developing and producing next generation and novel molecules.

Attend this conference to hear biobetter development strategies and biosimilar comparability studies from Centocor, Teva, Xencor, Amunix, Ambrx, Aegis, Antares, Macrogenics, Bayer, Biogen Idec, AnaptysBio, PharmaEssentia, Eureka, Amgen, Johnson & Johnson, Simcere, and more!

IBC's Bioprocess Training Academy course are two-day training sessions that allow you to gain new insight, evaluate industry standard practices and make new contacts in your field.

This course is a panoramic review of analytical method development and validation for therapeutic proteins, including antibodies and enzymes. It is intended for scientists working on therapeutic proteins in AD, QC, PD, or related functional areas.

In this course, you will learn strategies to plan and execute preformulation and formulation development studies of protein therapeutics, with the goal of maximizing the chemical, physical, conformational, and biological stability of the drug molecule while operating under accelerated timelines.